Patents-Review.com
ClassID:

111007 ⎘

C12N2760/18643 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Paramyxoviridae; Respirovirus, e.g. Bovine, human parainfluenza 1,3; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Recent Application in this class:
#1
20250325645
2025-10-23

BOVINE VIRAL DIARRHEA VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF

 #2
20250027111
2025-01-23

TEMPERATURE-BASED TRANSIENT DELIVERY OF NUCLEIC ACIDS AND PROTEINS TO CELLS AND TISSUES

 #3
20240309053
2024-09-19

RECOMBINANT HUMAN/BOVINE PARAINFLUENZA VIRUS 3 (B/HPIV3) EXPRESSING A CHIMERIC RSV/PIV3 F PROTEIN AND USES THEREOF

 #4
20230287055
2023-09-14

Recombinant human parainfluenza virus type 1 expressing a chimeric RSV/HPIV1 f protein and uses thereof

 #5
20230029979
2023-02-02

BROADLY PROTECTIVE BOVINE PARAINFLUENZA 3 VIRUS AND BOVINE VIRAL DIARRHEA VIRUS VACCINE

 #6
20220372518
2022-11-24

Temperature-based transient delivery of nucleic acids and proteins to cells and tissues

 #7
20220226458
2022-07-21

Recombinant chimeric bovine/human parainfluenza virus 3 expressing rsv g and its use

 #8
20210381005
2021-12-09

Temperature-based transient delivery of nucleic acids and proteins to cells and tissues

 #9
20210145958
2021-05-20

Recombinant chimeric bovine/human parainfluenza virus 3 expressing RSV G and its use

 #10
20200399718
2020-12-24

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

 #11
20200277338
2020-09-03

Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F protein and uses thereof

 #12
20180312544
2018-11-01

Recombinant human/bovine parainfluenza virus 3 (B/HPIV3) expressing a chimeric RSV/BPIV3 F protein and uses thereof

 #13
20180216200
2018-08-02

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

 #14
20180085449
2018-03-29

Anti-vaccine using sendai virus as vector

 #15
20180057894
2018-03-01

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

 #16
20170137899
2017-05-18

strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

 #17
20160346378
2016-12-01

SEMI-LIVE RESPIRATORY SYNCYTIAL VIRUS VACCINE

 #18
20160177337
2016-06-23

Method for production of reprogrammed cell using chromosomally unintegrated virus vector

 #19
20150337334
2015-11-26

Method for production of reprogrammed cell using chromosomally unintegrated virus vector

 #20
20140370497
2014-12-18

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

 #21
20130023030
2013-01-24

Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

 #22
20120294890
2012-11-22

Recombinant Parainfluenza Virus Expression Systems And Vaccines

 #23
20120045471
2012-02-23

RECOMBINANT PARAINFLUENZA VIRUS VACCINE COMPRISING HETEROLOGOUS ANTIGENS DERIVED FROM RESPIRATORY SYNCYTIAL VIRUS

 #24
20110287538
2011-11-24

Method for production of reprogrammed cell using chromosomally unintegrated virus vector

 #25
20110143422
2011-06-16

Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

 #26
20100330120
2010-12-30

HUMAN PARAINFLUENZA VIRUSES HAVING SEPARATED P AND C GENES

 #27
20100316991
2010-12-16

HUMAN PARAINFLUENZA VIRUS TYPE 3 EXPRESSING THE ENHANCED GREEN FLUORESCENT PROTEIN FOR USE IN HIGH-THROUGHPUT ANTIVIRAL ASSAYS

 #28
20100297730
2010-11-25

Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus

 #29
20100119547
2010-05-13

Recombinant parainfluenza virus expression systems and vaccines

 #30
20090263883
2009-10-22

Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus

 #31
20090246855
2009-10-01

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

 #32
20090004722
2009-01-01

Recombinant parainfluenza virus expression systems and vaccines

 #33
20080286848
2008-11-20

Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

 #34
20080096263
2008-04-24

Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus

 #35
20070281888
2007-12-06

Polypeptide promoting vascular endothelial cell growth

 #36
20070134271
2007-06-14

Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines

 #37
20050147623
2005-07-07

Recombinant parainfluenza virus expression systems and vaccines

 #38
20050142148
2005-06-30

Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus